Cover Image
市場調查報告書

肥大型心肌病:全球臨床實驗趨勢

Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 350318
出版日期 內容資訊 英文 47 Pages
訂單完成後即時交付
價格
Back to Top
肥大型心肌病:全球臨床實驗趨勢 Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2016
出版日期: 2016年07月29日 內容資訊: 英文 47 Pages
簡介

本報告提供肥大型心肌病治療藥相關之臨床實驗趨勢調查,提供您臨床實驗數量及受驗人數,各階段狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量

G7各國臨床實驗數量:心血管疾病治療藥臨床實驗上肥大型心肌病的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

肥大型心肌病治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3604CTIDB

GlobalData's clinical trial report, "Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2016" provides an overview of Hypertrophic Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Hypertrophic Cardiomyopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Hypertrophic Cardiomyopathy to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hypertrophic Cardiomyopathy Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Hypertrophic Cardiomyopathy
      • Jul 14, 2016: SHaRe Registry Data Published in PNAS Demonstrate the Power of Combining Clinical, Genetic and Structural Data to Gain Insight into Hypertrophic Cardiomyopathy
      • Jul 11, 2016: MyoKardia Announces Topline Clinical Data Supporting Advancement of MYK-461 to Phase 2 PIONEER-HCM Study in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
      • Definitions
      • Research Methodology
      • Secondary Research
      • About GlobalData
      • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Proportion of Hypertrophic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Hypertrophic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Proportion of Hypertrophic Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Hypertrophic Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Hypertrophic Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top